Summary

Report Scope
The current report will provide detailed exposure to the high-throughput screening (HTS) market. This report analyzes the market trends of HTS with data from 2023, estimates from 2024, projections of compound annual growth rates (CAGRs) through 2029 (forecast period is from 2024 through 2029) and regional HTS markets. This report will highlight the current and future market potential of HTS and present a detailed analysis of the competitive environment. It will also cover regulatory scenarios, drivers, restraints and opportunities. Lastly, it presents the market share for key market players.
The market scope in this report is segmented into detection method, component, technology and end user. The report covers spectroscopy, mass spectrometry, chromatography, calorimetry, X-ray diffraction and microscopy based on detection methods. These detection methods are further classified into subcategories for this report. The market is segmented based on components into instruments/
platforms, consumables (e.g., reagents, kits), services and software, and analytics (e.g., bioinformatics). The market is segmented based on technology: cell-based assays, ultra-high-throughput screening, label-free technology and lab-on-a-chip. End users are segmented into pharmaceutical and biotechnology companies, contract research organizations (CROs), research and government institutes, and lab and pathological practices.
The market has been segmented into significant geographical regions: North America, Europe, Asia-Pacific and other world regions. The regional segment will cover a detailed analysis of major countries, including the U.S., Canada, Germany, the U.K., Italy, Spain, France, Japan, China, South Korea, Australia and India. Data from 2023 will be provided as the base year for market estimates, with forecasts for 2024 through 2029.
The report’s goals include:
- Analyzing technologies, components, end users and applications.
- Analyzing global market size and segmentation.
- Understanding market constraints and drivers.
- Providing detailed market forecasts for 2029.
- Assessing market shares, competitiveness and industry structure.
- Identifying potential long-term impacts on the high-throughput screening market
Report Includes
- 154 data tables and 46 additional tables
- An analysis of the global market for high-throughput screening (HTS) technologies
- Analyses of the global market trends, with market revenue data (sales figures) from 2021 and 2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
- Estimates of the market size and revenue growth prospects, along with a market share analysis by component, application, technology type, detection method, end user, and region
- Facts and figures pertaining to key market dynamics, technology advances, regulations, and the impact of macroeconomic factors
- Insights derived from the Porter’s Five Forces model, as well as global supply chain analyses
- Analysis of patent activity, featuring key granted and published patents
- Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Company profiles of leading players, including Danaher Corp., Thermo Fisher Scientific Inc., Charles River Laboratories, Revvity and Bio-Rad Laboratories Inc.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of the Report
Market Summary
Chapter 2 Market Overview
Overview
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increased Adoption of Contract Research Organizations
Technological Innovation Leads to Advanced Tools and Methods
Rising Government Funding and Business Research and Development Expenditures
Rising Prevalence of Chronic and Immunological Diseases
Market Restraints
High Capital Investments in High-Throughput Screening
Assay Development Complexities and a Lack of Skilled Operators
Market Opportunities
HTS Evolution
Chapter 4 Emerging Technologies
Overview
Artificial Intelligence
Automation
Miniaturization
Patent Analysis
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Global Market for High-Throughput Screening by Detection Method
Global Market Size and Forecast
Spectroscopy
Mass Spectrometry
Chromatography
Biophysical Assay Services
X-Ray Diffraction
Microscopy
Global Market for High-Throughput Screening by Component
Global Market Size and Forecast
Instructions/Platforms
Consumables
Services
Software and Analytics
Global Market for High-Throughput Screening by Technology
Global Market Size and Forecast
Cell-Based Assays
Ultra-High-Throughput Screening
Label-Free Technology
Lab-on-a-Chip
Global Market for High-Throughput Screening by Application
Global Market Size and Forecast
Drug Discovery
Toxicity Studies
Biological Active Compound Screening
Protein Analysis
DNA Sequencing
Microarray Screening
Compound Profiling
Genomics Application
Global Market for High-Throughput Screening by End User
Global Market Size and Forecast
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Research and Government Institutes
Lab and Pathology Facilities
Geographic Breakdown
Global Market for High-Throughput Screening by Region
Global Market Size and Forecast
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Competitive Landscape
Company Share Analysis
Chapter 7 Sustainability in the High-Throughput Screening Market: An ESG Perspective
Introduction to ESG
Sustainability in the High-Throughput Screening Market
ESG Perspective
Environmental Impact
Social Impact
Governance Impact
Chapter 8 Appendix
Methodology
Abbreviations
Sources
Company Profiles
AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
BIO-TECHNE
BRUKER
CHARLES RIVER LABORATORIES
CORNING INC.
CREATIVE BIOLABS
CURIOX BIOSYSTEMS
DANAHER CORP.
EVOTEC SE
PROMEGA CORP.
REVVITY
THERMO FISHER SCIENTIFIC INC.
VALA SCIENCES INC.
ZEISS